Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Erritzoe

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Journal of Psychopharmacology (Oxford, England)|March 23, 2024
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depressionDavid Erritzoe, Tommaso Barba, Meg J Spriggs, et al.
Biochemistry|February 7, 2024
Membrane Permeation of Psychedelic Tryptamines by Dynamic SimulationsVito F Palmisano, Claudio Agnorelli, Andrea Fagiolini, et al.
Molecular Psychiatry|June 6, 2025
Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesRebecca Harding, Neomi Singer, Matthew B Wall, et al.
Molecular Psychiatry|October 6, 2025
Cortical 5-HT<sub>2A</sub> receptors in depression and suicide: a systematic review and meta-analysis of in vivo and post-mortem imaging studiesGeorge E Chapman, George Turner, Alexander P Noar, et al.
Frontiers in Psychiatry|July 16, 2021
Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity SampleKeri Mans, Hannes Kettner, David Erritzoe, et al.
Psychological Medicine|September 27, 2024
Validation of the imperial psychedelic predictor scaleMichael Angyus, Sarah Osborn, Eline Haijen, et al.
Translational Psychiatry|November 19, 2025
Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trialMarieke A G Martens, Bruna Giribaldi Cunha, David Erritzoe, et al.
Neuroscience Applied|July 14, 2025
An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteersKate Godfrey, Brandon Weiss, Xinhu Zhang, et al.
Psychological Medicine|August 26, 2025
Validation of the Imperial Psychedelic Predictor Scale - CORRIGENDUMMichael Angyus, Sarah Osborn, Eline Haijen, et al.
Human Psychopharmacology|June 15, 2012
Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological basesCecilie L Licht, Maria Christoffersen, Mads Okholm, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Journal of Psychopharmacology (Oxford, England)|March 23, 2024
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depressionDavid Erritzoe, Tommaso Barba, Meg J Spriggs, et al.
Biochemistry|February 7, 2024
Membrane Permeation of Psychedelic Tryptamines by Dynamic SimulationsVito F Palmisano, Claudio Agnorelli, Andrea Fagiolini, et al.
Molecular Psychiatry|June 6, 2025
Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesRebecca Harding, Neomi Singer, Matthew B Wall, et al.
Molecular Psychiatry|October 6, 2025
Cortical 5-HT<sub>2A</sub> receptors in depression and suicide: a systematic review and meta-analysis of in vivo and post-mortem imaging studiesGeorge E Chapman, George Turner, Alexander P Noar, et al.
Frontiers in Psychiatry|July 16, 2021
Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity SampleKeri Mans, Hannes Kettner, David Erritzoe, et al.
Psychological Medicine|September 27, 2024
Validation of the imperial psychedelic predictor scaleMichael Angyus, Sarah Osborn, Eline Haijen, et al.
Translational Psychiatry|November 19, 2025
Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trialMarieke A G Martens, Bruna Giribaldi Cunha, David Erritzoe, et al.
Neuroscience Applied|July 14, 2025
An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteersKate Godfrey, Brandon Weiss, Xinhu Zhang, et al.
Psychological Medicine|August 26, 2025
Validation of the Imperial Psychedelic Predictor Scale - CORRIGENDUMMichael Angyus, Sarah Osborn, Eline Haijen, et al.
Human Psychopharmacology|June 15, 2012
Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological basesCecilie L Licht, Maria Christoffersen, Mads Okholm, et al.
Pageof 15